Evidence map›Paper›PMID 38075673›Full record

ArticleJID innovations : skin science from molecules to population health2024

Automatic Urticaria Activity Score: Deep Learning-Based Automatic Hive Counting for Urticaria Severity Assessment.

Taig Mac Carthy, Ignacio Hernández Montilla, Andy Aguilar, Rubén García Castro, Ana María González Pérez, Alejandro Vilas Sueiro, Laura Vergara de la Campa, Fernando Alfageme, Alfonso Medela

Abstract read
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Taig Mac CarthyDepartment of Clinical Endpoint Innovation, Legit. Health, Bilbao, Spain.
Ignacio Hernández MontillaDepartment of Medical Computer Vision and PROMs, Legit.Health, Bilbao, Spain.
Andy AguilarDepartment of Clinical Endpoint Innovation, Legit. Health, Bilbao, Spain.
Rubén García CastroDermatology Unit, Fundación Jiménez Díaz Teaching University Hospital, Madrid, Spain.
Ana María González PérezDermatology Unit, Zamora Hospital Complex, Zamora, Spain.
Alejandro Vilas SueiroDermatology Unit, Ferrol Teaching University Hospital Complex, Ferrol, Spain.
Laura Vergara de la CampaDermatology Unit, Toledo Teaching University Hospital, Toledo, Spain.
Fernando AlfagemeDermatology Unit, Puerta de Hierro Hospital, Majadahonda, Madrid, Spain.
Alfonso MedelaDepartment of Medical Computer Vision and PROMs, Legit.Health, Bilbao, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic urticaria is a chronic skin disease that affects up to 1% of the general population worldwide, with chronic spontaneous urticaria accounting for more than two-thirds of all chronic urticaria cases. The Urticaria Activity Score (UAS) is a dynamic severity assessment tool that can be incorporated into daily clinical practice, as well as clinical trials for treatments. The UAS helps in measuring disease severity and guiding the therapeutic strategy. However, UAS assessment is a time-consuming and manual process, with high interobserver variability and high dependence on the observer. To tackle this issue, we introduce Automatic UAS, an automatic equivalent of UAS that deploys a deep learning, lesion-detecting model called Legit.Health-UAS-HiveNet. Our results show that our model assesses the severity of chronic urticaria cases with a performance comparable to that of expert physicians. Furthermore, the model can be implemented into CADx systems to support doctors in their clinical practice and act as a new end point in clinical trials. This proves the usefulness of artificial intelligence in the practice of evidence-based medicine; models trained on the consensus of large clinical boards have the potential of empowering clinicians in their daily practice and replacing current standard clinical end points in clinical trials.

Identifiers

PMID38075673
PMCPMC10698323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.